Valuation: Santen Pharmaceutical Co., Ltd.

Market Cap 549B 3.49B 3.07B 2.9B 2.63B 4.94B 335B 4.97B 34.46B 13.37B 171B 13.1B 12.82B P/E 2027 *
14.2x
P/E 2028 * 12.6x
Enterprise Value 502B 3.19B 2.81B 2.66B 2.41B 4.52B 306B 4.55B 31.53B 12.24B 156B 11.98B 11.73B EV / Sales 2027 *
1.65x
EV / Sales 2028 * 1.51x
Free-Float
96.88%
Yield 2027 *
2.43%
Yield 2028 * 2.74%
1 day-2.20%
Current month-8.82%
1 month-8.16%
3 months-19.66%
6 months-4.31%
Current year+5.17%
1 week 1,705
Extreme 1705
1,764
1 month 1,705
Extreme 1705
1,906.5
Current year 1,561.5
Extreme 1561.5
2,254
1 year 1,458
Extreme 1458
2,254
3 years 1,255
Extreme 1255
2,254
5 years 956
Extreme 956
2,254
10 years 956
Extreme 956
2,254
Manager TitleAgeSince
Chief Executive Officer 67 2022-08-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 67 2017-06-22
Director/Board Member 45 2024-05-31
Director/Board Member 48 2024-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.20%0.00%+4.59%+20.21% 3.57B
+0.11%+2.76%+63.52%+115.51% 1,055B
+0.27%+0.73%+51.33%+73.10% 654B
+0.73%+0.88%+20.70%+73.89% 467B
-1.36%-0.39%+40.20%+41.03% 348B
+1.34%+5.47%+23.37%+31.30% 275B
-0.48%-0.06%+13.56%+12.36% 258B
+0.85%+8.42%+53.17%+55.45% 224B
+0.85%+1.40%+35.78%+101.47% 187B
-0.30%-10.41%-27.62%-61.04% 171B
Average -0.19%+0.89%+27.86%+46.33% 364.19B
Weighted average by Cap. -0.12%+1.32%+40.66%+69.00%

Financials

2027 *2028 *
Net sales 304B 1.93B 1.7B 1.61B 1.46B 2.74B 185B 2.75B 19.08B 7.4B 94.67B 7.25B 7.09B 313B 1.99B 1.75B 1.65B 1.5B 2.81B 191B 2.83B 19.62B 7.61B 97.36B 7.46B 7.3B
Net income 38.22B 243M 214M 202M 183M 344M 23.3B 346M 2.4B 931M 11.9B 912M 892M 40.85B 259M 228M 216M 196M 368M 24.9B 370M 2.56B 995M 12.72B 974M 953M
Net Debt -46.74B -297M -261M -247M -224M -421M -28.49B -423M -2.93B -1.14B -14.55B -1.11B -1.09B -75.89B -482M -424M -401M -364M -683M -46.26B -687M -4.76B -1.85B -23.63B -1.81B -1.77B
Logo Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, and sale of pharmaceuticals. The Company engages in global research and development, manufacture, sale, and marketing of pharmaceuticals in the ophthalmology field. The Company engages in prescription pharmaceuticals, over-the-counter pharmaceuticals, medical devices, and other businesses. The Company operates in Japan, Asia, Europe, the Middle East, and Africa (EMEA), China, and other regions.
Employees
3,968
Date Price Change Volume
26-09-28 JP¥1,710.00 -2.20% 1,457,200
26-09-25 JP¥1,748.50 +0.72% 1,531,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
1,710.00JPY
Average target price
2,377.78JPY
Spread / Average Target
+39.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4536 Stock